| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 7. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | docetaxel (Taxotere®) |
| Formulation | concentrate for solution for infusion |
| Reference number | 1340 |
| Indication | Adjuvant treatment of patients with operable node-negative breast cancer in combination with doxorubicin and cyclophosphamide |
| Company | Sanofi-Aventis Ltd |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 17/11/2011 |